Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program | The Manila Times

HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the 'Company” or 'Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases ('NIAID”), part of the National Institutes of Health ('NIH”), in connection with the Company’s contract supporting development of the VXV-01 fungal vaccine candidate.

Ähnliche Seiten

https://www.manilatimes.net/2026/06/24/tmt-newswire/globenewswire/qmmm-announces-receipt-of-delisting-notice-from-nasdaq/2371423

QMMM Announces Receipt of Delisting Notice from Nasdaq | The Manila Times

https://www.manilatimes.net/2026/06/24/tmt-newswire/globenewswire/qmmm-announces-receipt-of-delisting-notice-from-nasdaq/2371423
https://www.manilatimes.net/2026/06/27/tmt-newswire/globenewswire/larimar-therapeutics-announces-investor-event-on-the-nomlabofusp-program-for-friedreichs-ataxia/2373971

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia | The Manila Times

https://www.manilatimes.net/2026/06/27/tmt-newswire/globenewswire/larimar-therapeutics-announces-investor-event-on-the-nomlabofusp-program-for-friedreichs-ataxia/2373971
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/structure-therapeutics-announces-publication-in-nature-medicine-highlighting-phase-2b-access-program-of-aleniglipron-for-obesity/2359859

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity | The Manila Times

https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/structure-therapeutics-announces-publication-in-nature-medicine-highlighting-phase-2b-access-program-of-aleniglipron-for-obesity/2359859
https://www.manilatimes.net/2026/06/17/tmt-newswire/globenewswire/jm-group-limited-announces-receipt-of-nyse-american-notice-of-delisting/2367068

JM Group Limited Announces Receipt of NYSE American Notice of Delisting | The Manila Times

https://www.manilatimes.net/2026/06/17/tmt-newswire/globenewswire/jm-group-limited-announces-receipt-of-nyse-american-notice-of-delisting/2367068
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/greenwave-announces-receipt-of-additional-delinquency-notice-from-nasdaq/2353184

Greenwave Announces Receipt of Additional Delinquency Notice from Nasdaq | The Manila Times

https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/greenwave-announces-receipt-of-additional-delinquency-notice-from-nasdaq/2353184
https://www.manilatimes.net/2026/07/04/tmt-newswire/globenewswire/ree-automotive-announces-receipt-of-nasdaq-delisting-notice/2378276

REE Automotive Announces Receipt of Nasdaq Delisting Notice | The Manila Times

https://www.manilatimes.net/2026/07/04/tmt-newswire/globenewswire/ree-automotive-announces-receipt-of-nasdaq-delisting-notice/2378276